Deal Library / Pharma BD Deal Intelligence

Vertex Pharmaceuticals Incorporated — Pharma Deals

The Pharma Closeout tracks 12 deals, $24.6B in disclosed deal value, 8 with a post-close Outcome Score for Vertex Pharmaceuticals Incorporated.

Median Critic Score: 86  ·  Median Outcome Score: 82

Best outcome: Vertex Pharmaceuticals Incorporated / Aurora Biosciences Corporation (95)  ·  Weakest outcome: Vertex Pharmaceuticals Incorporated / Exonics Therapeutics (54)

All 12 deals

• Vertex Pharmaceuticals Incorporated / Aurora Biosciences Corporation — 2001 · $592M · Worked — the deal delivered on its rationale.
• Vertex Pharmaceuticals Incorporated / Semma Therapeutics Inc. — 2019 · $950M · Worked — the deal delivered on its rationale.
• Vertex Pharmaceuticals Incorporated / Concert Pharmaceuticals, Inc. — 2017 · $250M · Worked — the deal delivered on its rationale.
• Vertex Pharmaceuticals Incorporated / CRISPR Therapeutics AG — 2015 · $2.6B · Worked — the deal delivered on its rationale.
• Vertex Pharmaceuticals Incorporated / Alpine Immune Sciences — 2024 · $4.9B · Worked — the deal delivered on its rationale.
• Vertex Pharmaceuticals Incorporated / Crinetics Pharmaceuticals, Inc. — 2026 · $10.0B · Largely worked — most objectives met.
• Vertex Pharmaceuticals Incorporated / ViaCyte Inc. — 2022 · $320M · Largely worked — most objectives met.
• Vertex Pharmaceuticals Incorporated / Exonics Therapeutics — 2005 · $1.0B · Mixed — partial payoff, real shortfalls.
• Vertex Pharmaceuticals Incorporated / CRISPR Therapeutics AG — 2023 · $330M
• Vertex Pharmaceuticals Incorporated / CRISPR Therapeutics AG — 2021 · $1.1B
• Vertex Pharmaceuticals Incorporated / Exonics Therapeutics — 2019 · $1.0B
• Vertex Pharmaceuticals Incorporated / Alios BioPharma, Inc. — 2011 · $1.5B

← Deal Library  ·  Interactive search  ·  How we score deals